Mutational Profiling Can Establish Clonal or Independent Origin in Synchronous Bilateral Breast and Other Tumors-Reference-Cited by-同舟云学术

Mutational Profiling Can Establish Clonal or Independent Origin in Synchronous Bilateral Breast and Other Tumors

Published:2015-11-10 Issue:11 Volume:10 Page:e0142487
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Bao Lei,Messer Karen,Schwab Richard,Harismendy Olivier,Pu Minya,Crain Brian,Yost Shawn,Frazer Kelly A.,Rana Brinda,Hasteh Farnaz,Wallace Anne,Parker Barbara A.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference35 articles.

1. Prognosis of early-stage synchronous bilateral invasive breast cancer;SM Schmid;Eur J Surg Oncol,2011

2. Magnetic resonance imaging screening of the contralateral breast in women with newly diagnosed breast cancer: systematic review and meta-analysis of incremental cancer detection and impact on surgical management;ME Brennan;J Clin Oncol,2009

3. Pathological and molecular characteristics distinguishing contralateral metastatic from new primary breast cancer;B Banelli;Ann Oncology,2010

4. Diagnostic and prognostic utility of molecular markers in synchronous bilateral breast carcinoma;RS Saad;Mod Pathol,2008

5. A case-match study comparing unilateral with synchronous bilateral breast cancer outcomes;AM Nichol;J Clin Oncol,2011

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Commentary: Genomic Analysis Reveals Heterogeneity Between Lesions in Synchronous Primary Right-Sided and Left-Sided Colon Cancer;Frontiers in Molecular Biosciences;2022-01-21

2. Molecular Imaging Reveals a High Degree of Cross-Seeding of Spontaneous Metastases in a Novel Mouse Model of Synchronous Bilateral Breast Cancer;Molecular Imaging and Biology;2021-07-26

3. Molecular imaging reveals a high degree of cross-seeding of spontaneous metastases in a novel mouse model of synchronous bilateral breast cancer;2020-11-27

4. Mitochondrial DNA analysis efficiently contributes to the identification of metastatic contralateral breast cancers;Journal of Cancer Research and Clinical Oncology;2020-11-24

5. Intratumoral Genomic Heterogeneity May Hinder Precision Medicine Strategies in Patients with Serous Ovarian Carcinoma;Diagnostics;2020-04-03